Table 1 8 groups of mice treated (n = 5).
From: KIAA1429 impairs anti-tumor immunity via regulation of PD-L1 and CD8+ T cells in colorectal cancer
Categorization | Group | Intratumoral Injections (2.5nmol, twice weekly) | Intraperitoneal Injections (200 µg, twice weekly) |
|---|---|---|---|
CT26 (BALB/c) | siNC group | siNC | / |
siNC + antiPD1 group | siNC | anti-PD1 | |
siKIAA1429 group | siKIAA1429 | / | |
siKIAA1429 + antiPD1group | siKIAA1429 | anti-PD1 | |
MC38 (C57BL/6) | siNC group | siNC | / |
siNC + antiPD1 group | siNC | anti-PD1 | |
siKIAA1429 group | siKIAA1429 | / | |
siKIAA1429 + antiPD1group | siKIAA1429 | anti-PD1 |
